Position in RZLT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$39,621,509
+$599,589 QoQ
Shares Held
12,990,659
-21.4% QoQ
Ownership
13.5%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FEDERATED HERMES, INC. holds $2,358,506,481 across 147 Biotechnology names. RZLT ranks #20 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
687,816 | $227,577,679 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
254,946 | $196,981,475 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,286,303 | $111,869,771 | |
| 4 | MRNA |
Moderna, Inc.
|
1,977,079 | $100,435,613 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
2,987,107 | $99,530,405 | |
| 6 | INSM |
INSMED Inc
|
538,257 | $88,015,784 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
2,049,439 | $81,403,717 | |
| 8 | EYPT |
EyePoint, Inc.
|
5,669,589 | $73,081,000 |
All Filings in RZLT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,621,509 | 12,990,659 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $39,021,920 | 16,534,712 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $131,926,292 | 14,034,712 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $62,594,815 | 14,034,712 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $32,710,048 | 11,279,327 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $55,268,702 | 11,279,327 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $54,704,735 | 11,279,327 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $48,501,106 | 11,279,327 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $25,893,533 | 10,154,327 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,083,246 | 10,154,327 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $8,725,561 | 6,610,274 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,088,342 | 6,610,274 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,691,726 | 6,610,274 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $13,683,267 | 6,610,274 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,112,150 | 6,610,274 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,351,185 | 6,610,274 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $10,779,570 | 3,189,222 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,244,481 | 3,189,222 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,065,460 | 1,212,122 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,296,980 | 1,212,122 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,557,581 | 1,212,122 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $14,533,342 | 1,212,122 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||